SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 44 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $280,211 | -33.3% | 150,000 | -40.0% | 0.00% | – |
| Q3 2022 | $420,000 | +32.9% | 250,000 | 0.0% | 0.00% | – |
| Q2 2022 | $316,000 | -3.7% | 250,000 | 0.0% | 0.00% | – |
| Q1 2022 | $328,000 | -10.4% | 250,000 | 0.0% | 0.00% | – |
| Q4 2021 | $366,000 | -1.6% | 250,000 | 0.0% | 0.00% | – |
| Q3 2021 | $372,000 | +12.0% | 250,000 | 0.0% | 0.00% | – |
| Q2 2021 | $332,000 | +1.5% | 250,000 | 0.0% | 0.00% | – |
| Q1 2021 | $327,000 | -46.4% | 250,000 | 0.0% | 0.00% | – |
| Q4 2020 | $610,000 | +18.0% | 250,000 | 0.0% | 0.00% | – |
| Q3 2020 | $517,000 | -10.1% | 250,000 | 0.0% | 0.00% | – |
| Q2 2020 | $575,000 | +55.0% | 250,000 | 0.0% | 0.00% | – |
| Q1 2020 | $371,000 | -23.7% | 250,000 | 0.0% | 0.00% | – |
| Q4 2019 | $486,000 | +47.3% | 250,000 | 0.0% | 0.00% | – |
| Q3 2019 | $330,000 | -56.9% | 250,000 | -28.6% | 0.00% | – |
| Q2 2019 | $766,000 | +23.2% | 350,000 | 0.0% | 0.00% | – |
| Q1 2019 | $622,000 | – | 350,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DeepCurrents Investment Group LLC | 55,277,000 | $84,644,000 | 4.13% |
| STEELHEAD PARTNERS LLC | 19,300,000 | $29,580,000 | 2.91% |
| LINDEN ADVISORS LP | 95,377,000 | $145,892,000 | 2.59% |
| WOLVERINE ASSET MANAGEMENT LLC | 89,141,000 | $136,310,000 | 1.98% |
| Verition Fund Management LLC | 14,735,000 | $22,403,000 | 0.88% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 20,376,000 | $31,177,000 | 0.68% |
| Nicholas Investment Partners, LP | 1,950,000 | $2,960,000 | 0.58% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 7,500,000 | $11,527,000 | 0.56% |
| SSI INVESTMENT MANAGEMENT LLC | 3,009,000 | $4,572,000 | 0.40% |
| Calamos Advisors LLC | 26,471,000 | $40,570,000 | 0.32% |